EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ITIH5 inhibits proliferation, adipogenic differentiation, and secretion of inflammatory cytokines of human adipose stem cells—A new key in treating obesity?

Tim Ruhl iD, Thomas M Sessler, Jana M Keimes, Justus P Beier iD, Sophia Villwock, Michael Rose iD, Edgar Dahl iD

The FASEB Journal · 2024

DOI: 10.1096/fj.202301366r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2024. Verfasst von Tim Ruhl und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic Surgery, Hand Surgery-Burn Center, University Hospital RWTH Aachen, Aachen, Germany. Hauptthemen laut MEDLINE: Cytokines, Tumor Necrosis Factor-alpha. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Faculty of the RWTH Aachen University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inter‐α‐trypsin inhibitor heavy chain 5 (ITIH5) is widely expressed in the human body, and it is detected to be particularly abundant in adipose tissue. ITIH5 expression is increased in people with obesity compared to lean persons and is decreased by diet‐induced weight loss. This suggests that ITIH5 may be involved in the development of adiposity and clinical metabolic variables, although its exact function remains unknown. We measured the protein concentration of ITIH5 in adipose samples from patients undergoing abdominoplasty and tested for correlation with the subjects' BMI as well as inflammatory mediators. We stimulated human adipose stem cells (ASCs) with recombinant (r)ITIH5 protein and tested for an effect on proliferation, differentiation, and immunosuppressive properties when the cells were exposed to an artificial inflammatory environment. We found positive correlations between ITIH5 levels and the BMI ( p < .001) as well as concentrations of inflammatory cytokines (TNF‐α, IL‐6, and MCP‐1) in adipose tissue ( p < .01). Application of the rITIH5 protein inhibited both proliferation ( p < .001) and differentiation of ASCs. Especially, the development of mature adipocytes was reduced by over 50%. Moreover, rITIH5 decreased the release of IL‐6 and MCP‐1 when the cells were exposed to TNF‐α and IL‐1β ( p < .001). Our data suggest that ITIH5 is an adipokine that is increasingly released during human adipose tissue development, acting as a regulator that inhibits proliferation and adipogenic differentiation of ASCs. ITIH5 thus presents itself as a positive regulator of adipose tissue homeostasis, possibly protecting against both hyperplasia and hypertrophy of adipose tissue and the associated chronic inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CytokinesTumor Necrosis Factor-alphaHumansInterleukin-6AdipocytesObesityAdipose TissueAdipogenesisImmunologic FactorsStem CellsCell ProliferationProteinase Inhibitory Proteins, Secretory

Stichwörter der Autor:innen

adipocyteadipogenesisadipokineadiposityfat tissue

Substanzen

CytokinesTumor Necrosis Factor-alphaInterleukin-6Immunologic FactorsITIH5 protein, humanProteinase Inhibitory Proteins, Secretory

Autor:innen und Institutionen

  • Department of Plastic Surgery, Hand Surgery-Burn Center, University Hospital RWTH Aachen, Aachen, Germany.
  • Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany.

ORCID-Profile: Tim Ruhl, Justus P Beier, Michael Rose, Edgar Dahl

Förderung

  • Medical Faculty of the RWTH Aachen University

Zitieren

APA

Ruhl, T., Sessler, T. M., Keimes, J. M., Beier, J. P., Villwock, S., Rose, M., & Dahl, E. (2024). ITIH5 inhibits proliferation, adipogenic differentiation, and secretion of inflammatory cytokines of human adipose stem cells—A new key in treating obesity?. The FASEB Journal. https://doi.org/10.1096/fj.202301366r

Vancouver

Ruhl T, Sessler TM, Keimes JM, Beier JP, Villwock S, Rose M, et al. ITIH5 inhibits proliferation, adipogenic differentiation, and secretion of inflammatory cytokines of human adipose stem cells—A new key in treating obesity?. The FASEB Journal. 2024. doi:10.1096/fj.202301366r

BibTeX
@article{Ruhl2024,
  author = {Ruhl, Tim and Sessler, Thomas M and Keimes, Jana M and Beier, Justus P and Villwock, Sophia and Rose, Michael and Dahl, Edgar},
  title = {ITIH5 inhibits proliferation, adipogenic differentiation, and secretion of inflammatory cytokines of human adipose stem cells—A new key in treating obesity?},
  journal = {The FASEB Journal},
  year = {2024},
  doi = {10.1096/fj.202301366r}
}
Kostenlos starten →